Works matching DE "DISEASE progression"
Results: 5000
A distinct autosomal recessive ocular anomaly in Chaharborj, Islamic Republic of Iran.
- Published in:
- Eastern Mediterranean Health Journal, 2012, v. 18, n. 1, p. 24, doi. 10.26719/2012.18.1.24
- By:
- Publication type:
- Article
Role of neutrophils in cutaneous leishmaniasis.
- Published in:
- Eastern Mediterranean Health Journal, 2010, v. 16, n. 10, p. 1055, doi. 10.26719/2010.16.10.1055
- By:
- Publication type:
- Article
PREVALENCE AND FACTORS ASSOCIATED WITH LATE DIAGNOSIS OF THE HIV INFECTION IN A MUNICIPALITY OF SÃO PAULO.
- Published in:
- Texto & Contexto Enfermagem, 2022, v. 31, p. 1, doi. 10.1590/1980-265X-TCE-2020-0579
- By:
- Publication type:
- Article
IMPACT OF COVID-19 IN PATIENTS WITH CANCER: A SCOPING REVIEW.
- Published in:
- Texto & Contexto Enfermagem, 2021, v. 30, p. 1, doi. 10.1590/1980-265X-TCE-2020-0415
- By:
- Publication type:
- Article
KNOWING THE FAMILY FUNCTIONALITY UNDER THE VIEW OF A CHRONICALLY ILL PATIENT.
- Published in:
- Texto & Contexto Enfermagem, 2012, v. 21, n. 4, p. 879
- By:
- Publication type:
- Article
Updates on the Management of Breast Cancer Brain Metastases.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 7, p. 572
- By:
- Publication type:
- Article
Double Trouble: A Case of Concurrent De Novo T790M and L858R EGFR Mutations in Treatment-Naive Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 526
- By:
- Publication type:
- Article
Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion?
- Published in:
- Oncology (08909091), 2014, v. 28, n. 1, p. 16
- By:
- Publication type:
- Article
When It Comes to the Efficacy of Metastasectomy, Biology Is King.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 11, p. 1051
- By:
- Publication type:
- Article
The Use of Serum hCG as a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Nonseminomatous Germ Cell Tumor of Testis and Interrupted Treatment.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Recurrent Epithelial Ovarian Cancer: An Update on Treatment.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 4, p. 288
- By:
- Publication type:
- Article
First-Line Erlotinib Inferior to Chemo in Advanced Lung Cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 930
- Publication type:
- Article
Which TKI Should Be Recommended as Initial Treatment for CML in Chronic Phase?
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Alpha Particles as Radiopharmaceuticals in the Treatment of Bone Metastases: Mechanism of Action of Radium-223 Chloride (Alpharadin) and Radiation Protection.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 4, p. 330
- By:
- Publication type:
- Article
New Way to Predict Prostate Cancer Severity: Size of Prostate.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 3, p. 309
- Publication type:
- Article
Sequencing of Therapies in Advanced Prostate Cancer.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 82
- By:
- Publication type:
- Article
Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 1, p. 70
- By:
- Publication type:
- Article
MGUS and Smoldering Myeloma: the Most Prevalent of Plasma Cell Dyscrasias.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 7, p. 594
- By:
- Publication type:
- Article
Multiple Myeloma Precursor Disease: Current Clinical and Epidemiological Insights and Future Opportunities.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 7, p. 589
- By:
- Publication type:
- Article
Management of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM).
- Published in:
- Oncology (08909091), 2011, v. 25, n. 7, p. 578
- By:
- Publication type:
- Article
Myth Busting: Does Real-World Experience Lead to Better Drug Choices?
- Published in:
- Oncology (08909091), 2010, v. 24, n. 14, p. 1272
- By:
- Publication type:
- Article
Phase III Data Show Octreotide Reduced Risk of Disease Progression by 66% in Advanced Neuroendocrine Tumor Patients.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 12, p. 1104
- Publication type:
- Article
A Structural Model of Health-Related Quality of Life in Parkinson’s Disease Patients.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Complex interactions between the DNA-damage response and mammalian telomeres.
- Published in:
- Nature Structural & Molecular Biology, 2015, v. 22, n. 11, p. 859, doi. 10.1038/nsmb.3092
- By:
- Publication type:
- Article
Accounting for Complexity.
- Published in:
- Science, Technology & Human Values, 2016, v. 41, n. 2, p. 194, doi. 10.1177/0162243915595462
- By:
- Publication type:
- Article
Surveillance for prostate cancer is generally safe, study results show.
- Published in:
- Urology Times, 2021, v. 49, n. 10, p. 12
- By:
- Publication type:
- Article
BPAs reduce fracture risk during combo treatment in metastatic CRPC: Data confirm importance of bone-protecting agents in this setting, investigator says.
- Published in:
- Urology Times, 2021, v. 49, n. 8, p. 21
- By:
- Publication type:
- Article
<sup>177</sup>Lu-PSMA-617 signi?cantly improves survival in metastatic CRPC: Bene? ts were also observed for objective response rate and disease control rate.
- Published in:
- Urology Times, 2021, v. 49, n. 7, p. 14
- By:
- Publication type:
- Article
Pivotal long-term data published for apalutamide in metastatic CSPC.
- Published in:
- Urology Times, 2021, v. 49, n. 6, p. 22
- By:
- Publication type:
- Article
The many facets of stone disease: a practical outlook on 24-hour urine and genetic testing.
- Published in:
- Urology Times, 2021, v. 49, n. 6, p. 15
- By:
- Publication type:
- Article
Combination of belzutifan plus cabozantinib is active in advanced RCC: Treatment shrank tumors in 88% of patients and led to a disease control rate of 90%.
- Published in:
- Urology Times, 2021, v. 49, n. 4, p. 34
- By:
- Publication type:
- Article
Apalutamide plus abiraterone reduces risk of progression in metastatic CRPC: Radiographic progression-free survival benefit was sustained across prespecified subgroups.
- Published in:
- Urology Times, 2021, v. 49, n. 3, p. 9
- By:
- Publication type:
- Article
Radiation therapy may hold promise for NMIBC, but evidence is limited.
- Published in:
- Urology Times, 2021, v. 49, n. 1, p. 9
- By:
- Publication type:
- Article
AS is a safe option for African American men with low-risk prostate cancer: Risk of metastasis and mortality did not increase for patients on active surveillance, data indicate.
- Published in:
- Urology Times, 2020, v. 48, n. 12, p. 21
- By:
- Publication type:
- Article
Active surveillance data show frequent upgrading, rare mortality.
- Published in:
- Urology Times, 2020, v. 48, n. 12, p. 9
- By:
- Publication type:
- Article
Nivolumab/cabozantinib combo impresses as frontline RCC treatment: Combination reduces risk of disease progression or death by 49% versus sunitinib.
- Published in:
- Urology Times, 2020, v. 48, n. 11, p. 32
- By:
- Publication type:
- Article
Metastatic Castration-Resistant Prostate Cancer: Real-World Implications of the CARD Study.
- Published in:
- Urology Times, 2020, v. 48, n. 11, p. 28
- Publication type:
- Article
Men on surveillance for prostate cancer may benefit from Mediterranean diet.
- Published in:
- Urology Times, 2020, v. 48, n. 10, p. 20
- By:
- Publication type:
- Article
Similar outcomes are observed with immediate vs delayed RP.
- Published in:
- Urology Times, 2020, v. 48, n. 9, p. 11
- By:
- Publication type:
- Article
Prostate Cancer/CLINICAL UPDATES. Ipatasertib plus abiraterone and prednisone improves radiographic PFS.
- Published in:
- Urology Times, 2020, v. 48, n. 7, p. 10
- By:
- Publication type:
- Article
Reduced bacillus Calmette-Guérin regimen: Is it feasible?
- Published in:
- Urology Times, 2020, v. 48, n. 6, p. 18
- By:
- Publication type:
- Article
6-month progression is strong survival surrogate in prostate cancer subset: Strongest surrogate marker for overall survival in men with metastatic hormone-sensitive disease.
- Published in:
- Urology Times, 2020, v. 48, n. 6, p. 12
- By:
- Publication type:
- Article
High-grade NMIBC linked with disease progression after bladder-sparing therapy: Data indicate high unmet need for novel bladder-sparing treatments.
- Published in:
- Urology Times, 2020, v. 48, n. 5, p. 6
- By:
- Publication type:
- Article
Surveillance safe for patients with Grade Group 1 prostate Ca: <1% risk of metastasis, prostate cancer-specific mortality in large study.
- Published in:
- Urology Times, 2020, v. 48, n. 4, p. 28
- By:
- Publication type:
- Article
Moderate activity seen with adding pembro to enza for mCRPC: Combination will continue to be evaluated in phase III trial, researcher reports.
- Published in:
- 2020
- By:
- Publication type:
- Interview
Tecentriq plus chemotherapy extends progression-free survival: Combination is new treatment option for patients with untreated metastatic urothelial carcinoma.
- Published in:
- Urology Times, 2019, v. 47, n. 11, p. 26
- By:
- Publication type:
- Article
Guide for adjuvant, salvage RT after RP amended: New evidence supports use of hormone therapy with salvage radiation after radical prostatectomy.
- Published in:
- Urology Times, 2019, v. 47, n. 11, p. 20
- By:
- Publication type:
- Article
PARP inhibitor significantly extends rPFS vs. hormonal therapy: Objective response rate, time to pain progression also favor olaparib, phase III data indicate.
- Published in:
- Urology Times, 2019, v. 47, n. 11, p. 1
- By:
- Publication type:
- Article
Top studies move BPH treatment forward: Leading research in 2018-'19 changes surgical approach, clinical guidance.
- Published in:
- Urology Times, 2019, v. 47, n. 11, p. 1
- By:
- Publication type:
- Article